Saltar al contenido
Merck
Todas las fotos(1)

Documentos

AG938

Sigma-Aldrich

Synuclein, α, recombinant human

Sinónimos:

α-Synuclein protein, Alpha Synuclein

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Código UNSPSC:
12352200
eCl@ss:
32160405
NACRES:
NA.41

origen biológico

human

Nivel de calidad

Análisis

>95% (gel scan and mass spectrometry)

formulario

solid

caducidad

12 mo.

fabricante / nombre comercial

Chemicon®

solubilidad

water: slightly soluble

idoneidad

suitable for molecular biology

Nº de acceso NCBI

Nº de acceso UniProt

Información sobre el gen

human ... SNCA(6622)

Descripción general

Research area: Neuroscience

α-Synuclein, a member of the synuclein family of proteins that localize to presynaptic terminals under physiological conditions. It is comprised of three primary regions: an amino terminus containing apolipoprotein lipid-binding motifs, which are anticipated to form amphiphilic helices. The central region, known as non-Aβ component (NAC) containing a hydrophobic domain that gives β-sheet potential, and the carboxyl terminus, characterized by a high negative charge and remains unstructured. Under physiological conditions, members of the synuclein family, including α-synuclein, are predominantly neuronal proteins.

Aplicación

Synuclein, α, recombinant human has been used:
  • for preparation of α-synuclein fibrils to access the SAR228810 antibody against the risk of amyloid-related imaging abnormalities (ARIA).
  • to study the formation of isoasparate protein damage responsible to trigger familial Parkionsonian phenotypes.
  • to study its interaction with iron and copper, in order to understand their role in proteinopathies.

Acciones bioquímicas o fisiológicas

Synuclein, α is the principal component of Lewy bodies and a pathological hallmark of synucleinopathies, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). The deposition of αS aggregates is a defining characteristic of all these diseases.

Forma física

Lyophilized from TBS. Resuspend in water at a concentration of 1 mg/mL.

Almacenamiento y estabilidad

Maintain lyophilized material at -20ºC for up to 12 months after date of receipt. After reconstitution maintain at -20ºC to -70ºC for up to 2 weeks in undiluted aliquots. Avoid freeze/thaw cycles to avoid aggregation.

Información legal

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Cláusula de descargo de responsabilidad

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Código de clase de almacenamiento

13 - Non Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 1

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Molecular ageing of alpha- and Beta-synucleins: protein damage and repair mechanisms
Vigneswara V, et al.
PLoS ONE, 8(4), e61442-e61442 (2013)
SAR228810: an antibody for protofibrillar amyloid ? peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA)
Pradier L, et al.
Alzheimer's Research & Therapy, 10(1), 117-117 (2018)
The many faces of ?-synuclein: from structure and toxicity to therapeutic target
Lashuel HA, et al.
Nature Reviews. Neuroscience, 14, 38-48 (2013)
Emerging Approaches to Investigate the Influence of Transition Metals in the Proteinopathies
Lermyte F, et al.
Cells, 8(10), 1231-1231 (2019)
Alpha-synuclein structure and Parkinson?s disease ? lessons and emerging principles
Meade RM, et al.
Mol. Neurodegener., 14 (2019)

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico